Document Detail

A pilot study on the acceptability of levonorgestrel-releasing intrauterine device by young, single, nulliparous Chinese females following surgical abortion.
MedLine Citation:
PMID:  14969674     Owner:  NLM     Status:  MEDLINE    
This study investigated the acceptability of the levonorgestrel-releasing intrauterine device (LNG-IUS) as contraception among young, single women after termination of pregnancy. Twenty subjects, with a median age of 21 years, had LNG-IUS inserted immediately after suction termination of first-trimester pregnancy. The subjects were followed-up at 6 weeks, 3 months, 6 months and 12 months. Fifteen subjects (75%) had other pregnancies terminated in the past. There were no serious complications or pregnancies. The acceptability of the LNG-IUS was generally above 86% during each follow-up visit. A total of seven (35%) subjects were lost to follow-up at different periods of the study. Overall, four subjects (22%) had the LNG-IUS removed. Nine subjects were seen at the end of the 1-year study period and all continued with the LNG-IUS for contraception. Side effects were commonly observed and irregular vaginal bleeding was the most common. We conclude that the LNG-IUS may be an acceptable method among selective young, single, nulliparous clients after termination of pregnancy and could be offered as an option of contraception to them. However, the small sample size and the high lost-to-follow-up rate are the major limitations of this study.
Chiu-fai Ivy Li; S S N Lee; T C Pun
Related Documents :
2358194 - Development of human embryos in the presence of a copper intrauterine device.
4028724 - Post-abortion insertion of mlcu 250 and mlcu 375--a comparative trial.
17303784 - Androgenicity of progestins in hormonal contraceptives and the risk of gestational diab...
12204784 - Contraceptive failure--results from a study conducted among women with accepted and una...
21333984 - Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for ...
25251634 - Fetal fraction in maternal plasma cell-free dna in the prediction of spontaneous preter...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Contraception     Volume:  69     ISSN:  0010-7824     ISO Abbreviation:  Contraception     Publication Date:  2004 Mar 
Date Detail:
Created Date:  2004-02-18     Completed Date:  2004-06-09     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0234361     Medline TA:  Contraception     Country:  United States    
Other Details:
Languages:  eng     Pagination:  247-50     Citation Subset:  IM    
Department of Obstetrics and Gynaecology, The University of Hong Kong, Queen Mary Hospital, No. 102 Pokfulum Road, Hong Kong, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Abortion, Induced
Contraceptive Agents, Female / administration & dosage*,  adverse effects
Follow-Up Studies
Intraoperative Period
Intrauterine Devices, Medicated / adverse effects,  utilization*
Levonorgestrel / administration & dosage*,  adverse effects
Patient Acceptance of Health Care / statistics & numerical data*
Pilot Projects
Prospective Studies
Reg. No./Substance:
0/Contraceptive Agents, Female; 797-63-7/Levonorgestrel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Failure of family-planning referral and high interest in advanced provision emergency contraception ...
Next Document:  Oral contraceptive use and risk of diabetes among Chinese women.